1. Home
  2. LXEO vs GHG Comparison

LXEO vs GHG Comparison

Compare LXEO & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • GHG
  • Stock Information
  • Founded
  • LXEO 2017
  • GHG 2004
  • Country
  • LXEO United States
  • GHG China
  • Employees
  • LXEO N/A
  • GHG N/A
  • Industry
  • LXEO
  • GHG Hotels/Resorts
  • Sector
  • LXEO
  • GHG Consumer Discretionary
  • Exchange
  • LXEO Nasdaq
  • GHG Nasdaq
  • Market Cap
  • LXEO 252.4M
  • GHG 259.8M
  • IPO Year
  • LXEO 2023
  • GHG 2018
  • Fundamental
  • Price
  • LXEO $4.88
  • GHG $2.57
  • Analyst Decision
  • LXEO Strong Buy
  • GHG
  • Analyst Count
  • LXEO 5
  • GHG 0
  • Target Price
  • LXEO $23.80
  • GHG N/A
  • AVG Volume (30 Days)
  • LXEO 210.0K
  • GHG 8.2K
  • Earning Date
  • LXEO 01-28-2025
  • GHG 02-25-2025
  • Dividend Yield
  • LXEO N/A
  • GHG 4.05%
  • EPS Growth
  • LXEO N/A
  • GHG N/A
  • EPS
  • LXEO N/A
  • GHG 0.28
  • Revenue
  • LXEO N/A
  • GHG $201,166,731.00
  • Revenue This Year
  • LXEO N/A
  • GHG N/A
  • Revenue Next Year
  • LXEO N/A
  • GHG $8.78
  • P/E Ratio
  • LXEO N/A
  • GHG $8.88
  • Revenue Growth
  • LXEO N/A
  • GHG N/A
  • 52 Week Low
  • LXEO $4.78
  • GHG $2.31
  • 52 Week High
  • LXEO $19.50
  • GHG $3.48
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 29.67
  • GHG 55.06
  • Support Level
  • LXEO $4.78
  • GHG $2.35
  • Resistance Level
  • LXEO $7.66
  • GHG $2.48
  • Average True Range (ATR)
  • LXEO 0.56
  • GHG 0.08
  • MACD
  • LXEO -0.17
  • GHG 0.02
  • Stochastic Oscillator
  • LXEO 3.47
  • GHG 91.67

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

Share on Social Networks: